SENP2-mediated SERCA2a DeSUMOylation Increases Calcium Overload in Cardiomyocytes to Aggravate Myocardial Ischemia/reperfusion Injury

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2023 Jul 18

PMID 37462038

Authors

Yuanyuan Luo

Shuaishuai Zhou

Tao Xu

Wanling Wu

Pingping Shang

Shuai Wang

Defeng Pan

Dongye Li

Affiliations

Soon will be listed here.

Abstract

Background: Sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) is a key protein that maintains myocardial Ca 2+ homeostasis. The present study aimed to investigate the mechanism underlying the SERCA2a-SUMOylation (small ubiquitin-like modifier) process after ischemia/reperfusion injury (I/RI) in vitro and in vivo .

Methods: Calcium transient and systolic/diastolic function of cardiomyocytes isolated from Serca2a knockout (KO) and wild-type mice with I/RI were compared. SUMO-relevant protein expression and localization were detected by quantitative real-time PCR (RT-qPCR), Western blotting, and immunofluorescence in vitro and in vivo . Serca2a-SUMOylation, infarct size, and cardiac function of Senp1 or Senp2 overexpressed/suppressed adenovirus infected cardiomyocytes, were detected by immunoprecipitation, triphenyltetrazolium chloride (TTC)-Evans blue staining, and echocardiography respectively.

Results: The results showed that the changes of Fura-2 fluorescence intensity and contraction amplitude of cardiomyocytes decreased in the I/RI groups and were further reduced in the Serca2a KO + I/RI groups. Senp1 and Senp2 messenger ribose nucleic acid (mRNA) and protein expression levels in vivo and in cardiomyocytes were highest at 6 h and declined at 12 h after I/RI. However, the highest levels in HL-1 cells were recorded at 12 h. Senp2 expression increased in the cytoplasm, unlike that of Senp1. Inhibition of Senp2 protein reversed the I/RI-induced Serca2a-SUMOylation decline, reduced the infarction area, and improved cardiac function, while inhibition of Senp1 protein could not restore the above indicators.

Conclusion: I/RI activated Senp1 and Senp2 protein expression, which promoted Serca2a-deSUMOylation, while inhibition of Senp2 expression reversed Serca2a-SUMOylation and improved cardiac function.

References

Ding L, Su X, Zhang W, Xu Y, Pan X . Gene Expressions Underlying Mishandled Calcium Clearance and Elevated Generation of Reactive Oxygen Species in the Coronary Artery Smooth Muscle Cells of Chronic Heart Failure Rats. Chin Med J (Engl). 2017; 130(4):460-469. PMC: 5324384. DOI: 10.4103/0366-6999.199825. View

Zhang Y, Jiao L, Sun L, Li Y, Gao Y, Xu C . LncRNA as a SERCA2a Inhibitor to Cause Intracellular Ca Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction. Circ Res. 2018; 122(10):1354-1368. PMC: 5959220. DOI: 10.1161/CIRCRESAHA.117.312117. View

Zsebo K, Yaroshinsky A, Rudy J, Wagner K, Greenberg B, Jessup M . Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ Res. 2013; 114(1):101-8. DOI: 10.1161/CIRCRESAHA.113.302421. View

Kawase Y, Ly H, Prunier F, Lebeche D, Shi Y, Jin H . Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol. 2008; 51(11):1112-9. DOI: 10.1016/j.jacc.2007.12.014. View

Zhai K, Zheng J, Tang Y, Li F, Lv Y, Zhang Y . The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis. Br J Pharmacol. 2017; 174(17):2818-2831. PMC: 5554322. DOI: 10.1111/bph.13885. View

Wu X, Xu T, Li D, Zhu S, Chen Q, Hu W . ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion. PLoS One. 2014; 8(12):e82957. PMC: 3875429. DOI: 10.1371/journal.pone.0082957. View

Miyamoto M, Del Monte F, Schmidt U, DiSalvo T, Kang Z, Matsui T . Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A. 2000; 97(2):793-8. PMC: 15410. DOI: 10.1073/pnas.97.2.793. View

Andersson K, Finsen A, Sjaland C, Winer L, Sjaastad I, Odegaard A . Mice carrying a conditional Serca2(flox) allele for the generation of Ca(2+) handling-deficient mouse models. Cell Calcium. 2009; 46(3):219-25. PMC: 4313567. DOI: 10.1016/j.ceca.2009.07.004. View

Kho C, Lee A, Hajjar R . Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy. Nat Rev Cardiol. 2012; 9(12):717-33. PMC: 3651893. DOI: 10.1038/nrcardio.2012.145. View

10.

Bae S, Jeong J, Park J, Kim S, Bae M, Choi S . Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem Biophys Res Commun. 2004; 324(1):394-400. DOI: 10.1016/j.bbrc.2004.09.068. View

11.

Kho C, Lee A, Jeong D, Oh J, Chaanine A, Kizana E . SUMO1-dependent modulation of SERCA2a in heart failure. Nature. 2011; 477(7366):601-5. PMC: 3443490. DOI: 10.1038/nature10407. View

12.

Cheng J, Kang X, Zhang S, Yeh E . SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007; 131(3):584-95. PMC: 2128732. DOI: 10.1016/j.cell.2007.08.045. View

13.

Heo K, Berk B, Abe J . Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events. Antioxid Redox Signal. 2015; 25(7):435-50. PMC: 5076483. DOI: 10.1089/ars.2015.6556. View

14.

Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J . Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2022; 33(6):357-366. DOI: 10.1016/j.tcm.2022.02.005. View

15.

Tokarz P, Wozniak K . SENP Proteases as Potential Targets for Cancer Therapy. Cancers (Basel). 2021; 13(9). PMC: 8123143. DOI: 10.3390/cancers13092059. View

16.

Du Y, Liu P, Xu T, Pan D, Zhu H, Zhai N . Luteolin Modulates SERCA2a Leading to Attenuation of Myocardial Ischemia/ Reperfusion Injury via Sumoylation at Lysine 585 in Mice. Cell Physiol Biochem. 2018; 45(3):883-898. DOI: 10.1159/000487283. View

17.

Ndrepepa G, Colleran R, Kastrati A . Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier. Coron Artery Dis. 2017; 28(3):253-262. DOI: 10.1097/MCA.0000000000000468. View

18.

Le N, Martin J, Fujiwara K, Abe J . Sub-cellular localization specific SUMOylation in the heart. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(8):2041-2055. PMC: 5716640. DOI: 10.1016/j.bbadis.2017.01.018. View

19.

Kang J, Gocke C, Yu H . Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem. 2006; 7:5. PMC: 1386686. DOI: 10.1186/1471-2091-7-5. View

20.

Zhai Y, Luo Y, Wu P, Li D . New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides. J Med Genet. 2018; 55(5):287-296. DOI: 10.1136/jmedgenet-2017-105120. View